Radujkovic, A., Dietrich, S., Andrulis, M., Benner, A., Longerich, T., Pellagatti, A., . . . Luft, T. (2016). Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy. Wiley.
Chicago Style (17th ed.) CitationRadujkovic, A., et al. Expression of CDKN1C in the Bone Marrow of Patients with Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Is Associated with Poor Survival After Conventional Chemotherapy. Wiley, 2016.
MLA引文Radujkovic, A., et al. Expression of CDKN1C in the Bone Marrow of Patients with Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Is Associated with Poor Survival After Conventional Chemotherapy. Wiley, 2016.